NFE2L1 and Miyoshi myopathy: Previously, Jindrich Sedlacek (2025) investigated the impact of proteostasis in MM, highlighting the role of NFE2L1 in the bounce-back response, a recovery pathway driven by NFE2L1, which contributes to maintaining proteasome activity via proteasome subunit resynthesis upon impairment of its function [44].